Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase NA 3Phase 1/2 2Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 14Leukemia, Myeloid, Acute 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia 12Multiple Myeloma 9Lymphoma 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 6Neoplasms, Plasma Cell 5Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Chronic-Phase 5Hematologic Neoplasms 5Congenital Abnormalities 5Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Accelerated Phase 4Primary Myelofibrosis 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Thrombocythemia, Essential 2Sezary Syndrome 2Recurrence 2Polycythemia Vera 2Myeloproliferative Disorders 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2

Interventions

fludarabine phosphate 2Polymerase Chain Reaction 2Flow Cytometry 2tipifarnib 1romidepsin 1motexafin gadolinium 1Vorinostat 1Thiotepa 1Therapeutics 1Tetradecanoylphorbol Acetate 1Tacrolimus 1Sunitinib 1Peripheral Blood Stem Cell Transplantation 1Methylprednisolone 1Melphalan 1MK 2206 1In Situ Hybridization, Fluorescence 1Immunologic Techniques 1Immunohistochemistry 1Immunoenzyme Techniques 1Imatinib Mesylate 1Filgrastim 1Fenretinide 1Etoposide 1Doxorubicin 1Decitabine 1Cytarabine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Neutrophilic, Chronic × Antilymphocyte Serum × Clear all
NCT00054236 2020-07-27

Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

Case Comprehensive Cancer Center

Phase 1 Completed
55 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Leukemia, Erythroblastic, Acute, Hodgkin Disease, Leukemia, Leukemia, Megakaryoblastic, Acute, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Recurrence, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡